Percutaneous Pulmonary Flow Restriction in Infants With Congenital Heart Disease

Matthew Warren1, Ana Vasquez Choy1, Mohammed Khan1

  • 1Children's Heart Institute, Children's Memorial Hermann Hospital, UTHealth, Houston, Texas, USA.

JACC. Advances
|August 12, 2024
PubMed

Insights

This study shows that percutaneous pulmonary blood flow (PBF) restriction is a safe, less invasive method for infants with congenital heart disease (CHD). It effectively controls PBF, allowing time for growth before surgery and reducing sternotomies.

Area of Science:

  • Pediatric Cardiology
  • Interventional Cardiology
  • Congenital Heart Disease

Background:

  • Pulmonary blood flow (PBF) restriction is crucial in infants with congenital heart disease (CHD) to prevent pulmonary over-circulation before definitive treatment.
  • Current surgical pulmonary artery banding has limitations and complications.

Purpose of the Study:

  • To evaluate a novel percutaneous technique for restricting PBF in select infants with CHD.
  • To assess the safety and efficacy of this less invasive approach.

Main Methods:

  • Modified vascular plug devices were percutaneously placed in bilateral branch pulmonary arteries.
  • Patients selected had CHD requiring PBF control due to low birth weight or prematurity.

Main Results:

  • Seven neonates with CHD underwent the procedure, demonstrating restricted PBF and decreased oxygen saturation (95% to 84%).
  • Five patients showed adequate PBF limitation on presurgical cardiac catheterization (mean PVR 1.52 WU×m², mTPG 5.9 mm Hg).
  • All patients proceeded to surgical intervention without major complications like device embolization.

Conclusions:

  • Percutaneous PBF restriction is a safe, less invasive alternative to surgical banding.
  • This technique facilitates somatic growth and gestational maturation by delaying surgical intervention.
  • It potentially reduces the number of sternotomies required for CHD treatment.
Abstract